Pok Yu Augustine Chow - 17 Mar 2023 Form 4 Insider Report for Imunon, Inc. (IMNN)

Reporting relationship: Director
Issuer ticker: IMNN
Reported as of: 17 Mar 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 21 Mar 2023, 16:41:58 UTC
Prior SEC filing: 15 Jun 2022
Source filing: View source filing
Reporting owner signature: /s/ Kimberly Bragg, VP of Finance & Controller

Key filing fact

Pok Yu Augustine Chow filed Form 4 for Imunon, Inc. (IMNN) on 21 Mar 2023.

Key facts

This page summarizes Pok Yu Augustine Chow's Form 4 filing for Imunon, Inc. (IMNN).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 21 Mar 2023, 16:41.

Change

Previous filing in this sequence was filed on 15 Jun 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IMNN transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +2,000
Change %: +12%
Price: $0.000000
Shares after: 18,429
Date: 17 Mar 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,000
Exercise price: $1.32
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents the closing price of Imunon, Inc. Common Stock on the date of grant.

Footnote F2

The options vest as follows: 1/3 on the date of grant; 1/3 on the on the one year anniversary of the date of grant; and 1/3 on the second year anniversary of the date of grant.